Irving Investors irvinginvestors.com

Irving Investors is an event driven equity fund that also participates in private investment opportunities. Irving looks at all areas of the market and focuses on high growth companies and disruptive technologies.

Irving Investors is an event driven equity fund that also participates in private investment opportunities. Irving looks at all areas of the market and focuses on high growth companies and disruptive technologies.

See All Exits Recent Exits

Phone: 212.671.1100

Fax:

205 Detroit St
Ste 400
 Denver, 80206
 Colorado, United States

Irving Investors - Investments & Acquisitions

Show Real Data Irving Investors Investments
See all Recent Investments
Date Company Round Amount Co-investors
2021-03-02eGenesisSeries C$125MAlta Partners, Altium Capital, ARCH Venture Partners, Catalio Capital Management, Farallon Capital Management, Fresenius Medical Care Ventures, HBM Healthcare Investments, Invus Group, Khosla Ventures, Leaps by Bayer, LifeSci Venture Partners, Monashee Investment Management, Osage University Partners, Polaris Partners, Samsara BioCapital, SymBiosis, and Wellington Partners
2020-11-19Imago BioSciencesSeries C$80MAmgen Ventures, BlackRock, Blackstone, Farallon Capital Management, Frazier Healthcare Partners, Greenspring Associates, HighLight Capital, Kingdon Capital Management, MRL Ventures, Omega Fund Management, Pharmaron, Surveyor Capital, T. Rowe Price, and Xeraya Capital
2020-11-09Prometheus BiosciencesSeries D$130MAGI Partners, Cedars-Sinai Medical Center, Cormorant Capital, Cowen, Eventide Asset Management, Nestle, Perceptive Advisors, Point72 Asset Management, and RTW Investments
2020-07-28Praxis Precision MedicinesSeries C - II$110MAdage Capital Management, Ample Plus Fund, Avoro Capital Advisors, Blackstone, Cormorant Asset Management, Eventide Asset Management, Novo Holdings, OCV Partners, Point72 Ventures, Qatar Investment Authority, Surveyor Capital, Verition Fund Management, and Vida Ventures
2020-06-30Goldfinch BioSeries B$100MAlly Bridge Group, BlackRock, Casdin Capital, Eventide Asset Management, Gilead Sciences, Schroder Adveq, Undisclosed Investors, Wellington Management, and Yonjin Venture
See all 5 investments